Latest Quarterly Sales News

Fortescue shipped 46.8 million tonnes of iron ore in the September quarter, but sales fell 3.9Mt short as negotiations with China Mineral Resources Group remained unresolved. Costs rose, net debt climbed to US$2.8 billion and inventory is expected to increase further, even as the miner advanced its Blacksmith and green technology projects.

Generation Development Group started FY27 with group funds under management up 29% to $48.1 billion, led by record quarterly inflows at Generation Life and resilient growth at Evidentia. The update also points to new commercial opportunities for Lonsec in investment governance, although it contains no earnings or cash flow figures.

Harris Technology has started FY27 with $4.3 million in quarterly revenue, positive operating cash flow and a sharp reduction in borrowings. Refurbished technology accounted for about 60% of sales, although parts delays constrained August and September activity.

Beach Energy delivered its strongest quarterly revenue result on record, with sales rising 41% to A$565 million as production increased 9% to 5.4 MMboe. Waitsia reliability improved, offshore abandonment work was completed and FY27 guidance remained unchanged.

CurveBeam AI has secured its strongest first-quarter HiRise sales result, gained China regulatory clearance and raised A$7.35 million to fund the next stage of commercialisation. The progress comes alongside lower customer receipts and a reported 4.3 quarters of cash runway.

icetana AI has started FY27 with a sharp lift in recurring revenue and quarterly sales, while its Antara Core platform reached its first commercial deployment. The progress came alongside higher operating cash outflows and a $3.9 million cash balance.

ECS Botanics has delivered a fifth consecutive quarter of positive operating cash flow, while branded sales and international expansion continue to reshape the business. The next test is whether planned UK and Polish launches can convert into recurring revenue.

TAL Daiichi Life Australia has tabled a conditional $11.80-per-share proposal to acquire the 79.5% of Challenger it does not already own. The approach arrives as Challenger reports a 52% jump in first-quarter sales, but remains non-binding and subject to due diligence, regulatory approval and a board recommendation.

FOS Capital has started FY27 ahead of its own expectations, reporting a 64% rise in quarterly sales and a stronger-than-forecast EBITDA result. The order book has expanded to $10.5 million, while major lighting wins and a $130 million quote pipeline support management’s expectation of similarly strong sales in 2Q27.

Elixinol Wellness lifted Q3 gross profit 27% and delivered a fourth consecutive quarter of positive underlying operating cash flow, despite statutory operating cash flow remaining negative and cash below A$1 million. The proposed all-scrip Vitable acquisition could add scale, but shareholder approval and a thin liquidity buffer remain important next tests.

Memphasys has reported record September-quarter invoiced revenue of A$211,000 as its Felix fertility device moves into more international markets. The commercial progress comes alongside A$3.5 million in funding, but the loan still requires shareholder approval for conversion into notes.

Lifestyle Communities recorded a sharp slowdown in both new and established home sales in the first quarter, as Victorian downsizers took longer to commit. Net debt fell by $8.4 million, but forthcoming VCAT refund payments will draw on working capital and existing debt facilities.